A novel estradiol/estrogen receptor alpha-dependent transcriptional mechanism controls expression of the human prolactin receptor (Q40285128)

19 September 2017

title

A novel estradiol/estrogen receptor alpha-dependent transcriptional mechanism controls expression of the human prolactin receptor (English)

1 reference

19 September 2017

Juying Dong

1

1 reference

19 September 2017

Chon-Hwa Tsai-Morris

series ordinal

2

1 reference

19 September 2017

Maria L Dufau

series ordinal

3

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 May 2006

1 reference

Journal of Biological Chemistry

19 September 2017

published in

1 reference

19 September 2017

volume

281

1 reference

19 September 2017

issue

27

1 reference

19 September 2017

page(s)

18825-18836

1 reference

Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice.

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

Human relevance of rodent prolactin-induced non-genotoxic mammary carcinogenesis: prolactin involvement in human breast cancer and significance for toxicology risk assessments

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

Isolation and characterization of two novel forms of the human prolactin receptor generated by alternative splicing of a newly identified exon 11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

Quantification of prolactin receptor mRNA in multiple human tissues and cancer cell lines by real time RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

Human prolactin receptor variants in breast cancer: low ratio of short forms to the long-form human prolactin receptor associated with mammary carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

Prognostic significance of serum prolactin levels in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

Human prolactin and its antagonist, hPRL-G129R, regulate bax and bcl-2 gene expression in human breast cancer cells and transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

Recurrent breast cancer treated with the antioestrogen tamoxifen: correlation between hormonal changes and clinical course

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

cis-acting elements and trans-acting proteins in the transcription of chorionic gonadotropin/luteinizing hormone receptor gene in human choriocarcinoma cells and placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

Estradiol stimulates expression of two human prolactin receptor isoforms with alternative exons-1 in T47D breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

Transcriptional regulation of the generic promoter III of the rat prolactin receptor gene by C/EBPbeta and Sp1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

Ecto-5'-nucleotidase (CD73) in multidrug-resistant cell lines generated by doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

Steroidogenic factor-1 is an essential transcriptional activator for gonad-specific expression of promoter I of the rat prolactin receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

Repression of the luteinizing hormone receptor gene promoter by cross talk among EAR3/COUP-TFI, Sp1/Sp3, and TFIIB

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

Estrogen receptor pathways to AP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

17 beta-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

Repression of interleukin-6 gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

Repression of the Interleukin-6 Promoter by Estrogen Receptor Is Mediated by NF-κB and C/EBPβ

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

Involvement of CCAAT/enhancer-binding protein and nuclear factor-kappa B binding sites in interleukin-6 promoter inhibition by estrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

CCAAT-enhancer-binding proteins (C/EBP) regulate the tissue specific activity of the CD11c integrin gene promoter through functional interactions with Sp1 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

A novel cis-acting element controlling the rat CYP2D5 gene and requiring cooperativity between C/EBP beta and an Sp1 factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

A nucleoprotein complex containing Sp1, C/EBP beta, and HMGI-Y controls human insulin receptor gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

The ability of C/EBP beta but not C/EBP alpha to synergize with an Sp1 protein is specified by the leucine zipper and activation domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

Nuclear receptors modulate the interaction of Sp1 and GC-rich DNA via ternary complex formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

Interaction of human thyroid hormone receptor beta with transcription factor TFIIB may mediate target gene derepression and activation by thyroid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

Unliganded thyroid hormone receptor inhibits formation of a functional preinitiation complex: implications for active repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

The vitamin D receptor interacts with general transcription factor IIB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

Retinoid X and retinoic acid receptors interact with transcription factor II-B by distinct mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

Specificity of cyclin E-Cdk2, TFIIB, and E1A interactions with a common domain of the p300 coactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

Prolactin receptor gene diversity: structure and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

Prolactin as a local growth promoter in patients with breast cancer: GCRI experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

Stage-dependent depression of melatonin in patients with primary breast cancer. Correlation with prolactin, thyroid stimulating hormone, and steroid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512826200

21 January 2018

Identifiers

DOI

10.1074/JBC.M512826200

1 reference

19 September 2017

1 reference